tyrosine has been researched along with regorafenib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amani, AM; Dehaen, W; Ramezanpour, S; Shiri, P | 1 |
| Al Shughri, A; Brunn, A; Fink, GR; Galldiks, N; Kabbasch, C; Langen, KJ; Rosen, EK; Rueß, D; Ruge, MI; Stetter, I; Tscherpel, C; Werner, JM; Werr, L; Wollring, MM | 1 |
| Bang, G; Kim, EG; Kim, HB; Kim, JY; Lee, GW; Oh, K; Park, JH; Park, JJ; Shin, EY | 1 |
1 review(s) available for tyrosine and regorafenib
| Article | Year |
|---|---|
A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy.
Topics: Humans; Indazoles; Neoplasms; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Quinolines; Sulfonamides; Tyrosine | 2022 |
2 other study(ies) available for tyrosine and regorafenib
| Article | Year |
|---|---|
Multimodal imaging findings in patients with glioblastoma with extensive coagulative necrosis related to regorafenib.
Topics: Brain Neoplasms; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Necrosis; Positron-Emission Tomography; Tyrosine | 2023 |
Defining regorafenib as a senomorphic drug: therapeutic potential in the age-related lung disease emphysema.
Topics: Animals; Cellular Senescence; Emphysema; Mice; Pulmonary Emphysema; Respiratory Distress Syndrome; Senotherapeutics; Swine; Tyrosine | 2023 |